N-acetylcysteine in bulimia nervosa - Open-label trial

Eating Behaviors

Volumn 14, Issue 1, 2013, Pages 87-89

  Guerdjikova, Anna I ^a,b   Blom, Thomas J ^a,b   Mori, Nicole ^a,b   McElroy, Susan L ^a,b  

^a LINDNER CENTER OF HOPE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bulimia nervosa; Eating disorders; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ATOMOXETINE; FLUOXETINE;

ADULT; ARTICLE; BULIMIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; DRUG ERUPTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PRURITUS; TREATMENT DURATION; TREATMENT RESPONSE;

ACETYLCYSTEINE; ADULT; AGED; BINGE-EATING DISORDER; BULIMIA NERVOSA; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871852625     PISSN: 14710153     EISSN: 18737358     Source Type: Journal    
DOI: 10.1016/j.eatbeh.2012.11.001     Document Type: Article

References (13)

1. Diagnostic and statistical manual of mental disorders, DSM-IV-TR (revised 4th ed., text rev;) 2000, (Washington, DC). A.P.A. (Ed.).
2. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder-A double-blind randomized placebo-controlled trial. Biological Psychiatry 2008, 64(6):468-475.
3. Dean O., Giorlando F., Berk M. N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. Journal of Psychiatry & Neuroscience 2010, 36(2):78-86.
4. First Michael B., Spitzer Robert L., Gibbon Miriam, Williams Janet B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition 2002, Biometrics Research, New York State Psychiatric Institute, (SCID-I/P) New York.
5. Grant J.E., Odlaug B.L., Kim S.W. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Archives of General Psychiatry 2009, 66(7):756-763.
6. Guy W. ECDEU Assessment Manual for Psychopharmacology, U.S. Department of Health, Education, and Welfare publication (ADM) 1976, National Institute of Mental Health, Rockville,Md.
7. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 1960, 23:56-62.
8. Hay P.J., Bacaltchuk J. Psychotherapy for bulimia nervosa and binging. Cochrane Database of Systematic Reviews 2003, (1):CD000562.
9. Hay P.J., Bacaltchuk J. Bulimia nervosa. Clinical Evidence (online) 2008, (2008).
10. Mazure C.M., Halmi K.A., Sunday S.R., Romano S.J., Einhorn A.M. The Yale-Brown-Cornell Eating Disorder Scale: Development, use, reliability and validity. Journal of Psychiatric Research 1994, 28(5):425-445.
11. McElroy S.L., Guerdjikova A.I., Martens B., Keck P.E., Pope H.G., Hudson J.I. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009, 23(2):139-156.
12. Rezin G.T., Amboni G., Zugno A.I., Quevedo J., Streck E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochemical Research 2009, 34(6):1021-1029.
13. Tsaluchidu S., Cocchi M., Tonello L., Puri B.K. Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 2008, 8(Suppl. 1):S5.